HCC

Medivir's CEO: “The IND approval is a very important milestone”

Medivir CEO: “IND approval is a very important milestone”

Medivir has received FDA approval to initiate a Phase IIb study to evaluate fostrox in combination with Lenvima in other...

Intervju
BioInvent deepens collaboration with MSD

Medivir in new clinical collaboration with Eisai  

Medivir has entered into a cooperation and supply agreement with...
Q2 marked continued progress for Medivir in advanced liver cancer

Q2 saw continued progress for Medivir in advanced liver cancer

Medivir presented greatly improved results for patients with...
Medivir

Medivir presents promising results in difficult-to-treat patient population

Medivir today presents new clinical data from its...

Intervju
Medivir aims for accelerated FDA approval through issuance

Medivir aims for accelerated FDA approval through issuance

Hepatocellular carcinoma is the most common form of primary...
Medivir's CEO: "We have attracted interest from the best investigators and hospitals to be part of the phase IIb study"

Medivir's CEO comments on the ongoing rights issue

Medivir is currently conducting a rights issue of up...

Intervju

NeuroVive looks ahead supported by strong preclinical results

NeuroVive Pharmaceuticals' full-year 2016 financial report offered no...